Skip to content
Canadian Pharmacy Regulatory Authorities:
AB
BC
MB
NB
NL
NS
NT
NU
ON
PE
QC
SK
YT
All
Search for:
Search
Search
National Drug Schedules
Menu Toggle
National Drug Schedules Program
Menu Toggle
What Are the National Drug Schedules (NDS)?
NDS Policies
Implementation of the NDS Across Canada
Subscribe to NDS Updates
National Drug Schedules Applications
National Drug Scheduling Process
Menu Toggle
Participation in NDS Reviews
National Drug Scheduling Advisory Committee (NDSAC)
Menu Toggle
NDSAC Meetings
Resources
Menu Toggle
Publications
NAPRA Diagnostic Tool and Learning Modules (DTLM)
National Statistics
Pharmacy Regulatory Authorities
Online Pharmacies
International
News
National Drug Schedules
Menu Toggle
National Drug Schedules Program
Menu Toggle
What Are the National Drug Schedules (NDS)?
NDS Policies
Implementation of the NDS Across Canada
Subscribe to NDS Updates
National Drug Schedules Applications
National Drug Scheduling Process
Menu Toggle
Participation in NDS Reviews
National Drug Scheduling Advisory Committee (NDSAC)
Menu Toggle
NDSAC Meetings
Resources
Menu Toggle
Publications
NAPRA Diagnostic Tool and Learning Modules (DTLM)
National Statistics
Pharmacy Regulatory Authorities
Online Pharmacies
International
News
Login
NAPRA Groups
Main Menu
National Drug Schedules
Menu Toggle
National Drug Schedules Program
Menu Toggle
What Are the National Drug Schedules (NDS)?
NDS Policies
Implementation of the NDS Across Canada
Subscribe to NDS Updates
National Drug Schedules Applications
National Drug Scheduling Process
Menu Toggle
Participation in NDS Reviews
National Drug Scheduling Advisory Committee (NDSAC)
Menu Toggle
NDSAC Meetings
Resources
Menu Toggle
Publications
NAPRA Diagnostic Tool and Learning Modules (DTLM)
National Statistics
Pharmacy Regulatory Authorities
Online Pharmacies
International
News
Login
NAPRA Groups
Brexucabtagene autoleucel
Brexucabtagene autoleucel
Approval Date:
July 23, 2021
Schedule:
I
Footnote:
PDL
